GlassScriptPhysician profile
Hugh Lavery
NPI 1326265281
$10,719.21
in general payments reported to CMS, 2019-2025
21 companies · $996 in 2025
The $996 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $490 · 2020: $1,051 · 2021: $2,736 · 2022: $2,534 · 2023: $1,434 · 2024: $1,477 · 2025: $996.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,378 · Consulting Fee: $524 · Education: $5.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,378.19 |
| Consulting Fee | $524.00 |
| Education | $5.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,545.76 | 2019-2024 | Lithoclast, Spaceoar Vue System - 10ml, Lithovue |
| Intuitive Surgical, INC. | $1,108.76 | 2022 | |
| Urogen Pharma, INC. | $1,053.38 | 2021-2025 | Jelmyto |
| Karl Storz Endoscopy-America | $875.10 | 2023-2025 | N.A., Flex-X |
| Edap Technomed INC | $615.80 | 2024-2025 | |
| Cook Medical LLC | $377.63 | 2022-2023 | Fiber Dust, Cook |
| Ambu INC. | $263.49 | 2023-2024 | |
| Procept Biorobotics Corporation | $171.66 | 2024 | Aquabeam System |
| Teleflex LLC | $144.52 | 2024 | |
| Coloplast Corp | $132.34 | 2021 | |
| Koelis INC. | $121.33 | 2022 | |
| Urovant Sciences INC | $48.36 | 2022 | |
| Abbvie INC. | $38.63 | 2025 | |
| Endo USA, INC. | $36.69 | 2025 | Xiaflex, Aveed, Edex |
| Ethicon INC. | $35.89 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $35.09 | 2019-2020 | |
| 180 Medical, INC. | $31.74 | 2019-2020 | |
| Neotract INC. | $31.52 | 2020 | |
| Astellas Pharma US INC | $19.57 | 2019 | |
| Janssen Biotech, INC. | $18.09 | 2019 | |
| Pfizer INC. | $13.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hugh Lavery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.